Reticulated platelets – a new risk factor of atherothrombosis?

Abstract

In this review we described the properties of reticulated platelets (RP) and showed how variations of their content might influence platelet activity, efficacy of antiplatelet drugs and the rate of thrombotic events in patients with cardiovascular diseases. RP represent a minor platelet fraction containing residual RNA from megakaryocytes. Platelets have no nucleus and do not synthesize RNA de novo, and RNA of megakaryocytic origin is destroyed during their circulation. That is why only recently produced “young” platelets contain RNA. In healthy donors RP are identified by staining with the RNA specific fluorescent dyes by flow cytofluorimetry or using standard protocols in modern flow haematological analyzers. RP content in blood reflects the level of thrombocytopoesis in the bone marrow. RP on average amounted from 3 to 10% of all platelets in the circulation depending on the method applied for their determination. RP absolute amount and/or their percentage is changed in haematological diseases associated with the alterations of megakaryocyte productive properties. RT measurements in patients with cardiovascular diseases have shown that their content is increased in acute coronary syndrome patients. RP are larger and functionally more active in comparison with not reticulated forms. They more frequently incorporate into the platelet aggregates and contain more intracellular granules. Increase of RT content in the circulation correlates with the increase of the average size and functional activity in the whole platelet population. High RP content in patients with cardiovascular diseases reduces antiaggregative effects of aspirin and P2Y12 APD receptor antagonists and increases the risk of atherothrombotic events.

Features of Platelet Hemostasis in Patients with Various Sensitivity to Anti-Platelet Therapy in Different Terms of Q-wave Myocardial Infarction

“…Согласно литературным данным, отмечается связь размера тромбоцитов с их функциональной активностью [8,9]. В результате активации тромбоцитов их дискоидная форма меняется на сферическую, появляются псевдоподии, что ведет к увеличению размеров клетки, при этом увеличивается показатель MPV в общем анализе Особенности тромбоцитарного гемостаза у пациентов с различной чувствительностью к антитромбоцитарной терапии в разные сроки Q-инфаркта миокарда «Рецепт», 2022, том 25, № 4 крови.…”

“…Интерпретация результатов импедансной агрегометрии аналогична оптической [7]. Современные гематологические анализаторы позволяют определять не только количество тромбоцитов в периферической крови, но их морфометрические характеристики, которые отражают оценку функциональной активности тромбоцитов и их тромбогенности [8,9].…”